# A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)

> **NCT00160511** · PHASE2 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 170 (—)

## Conditions studied

- Neuralgia, Postherpetic

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT00160511
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2005-08
- **Final completion:** 2005-09
- **Target enrollment:** 170 (—)
- **Last updated:** 2013-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00160511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00160511, "A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00160511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*